731.79MMarket Cap-16.92P/E (TTM)
8.780High8.260Low2.51MVolume8.540Open8.470Pre Close21.62MTurnover3.06%Turnover RatioLossP/E (Static)84.80MShares10.45052wk High5.64P/B709.44MFloat Cap3.25052wk Low--Dividend TTM82.21MShs Float31.500Historical High--Div YieldTTM6.14%Amplitude0.600Historical Low8.597Avg Price1Lot Size
Anavex Life Sciences Stock Forum
$Sunshine Biopharma (SBFM.US)$
$Rumble (RUM.US)$
Got a few superbouncy balls this evening.
making me dizzy 🤣
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Anavex Life Sciences (Nasdaq: AVXL) announced it will present new long-term data from the Phase IIb/III ATTENTION-AD Open-Label-Extension (OLE) trial for blarcamesine in early Alzheimer's disease at the J.P. Morgan 2025 Healthcare Conference. The presentation will showcase data from up to 144 weeks of continuous treatm...
No comment yet